Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Korean Journal of Perinatology ; : 286-291, 2012.
Article in Korean | WPRIM | ID: wpr-59319

ABSTRACT

Hypertension is common medical problem encountered during pregnancy. However medication administered for maternal hypertension may cause fetal or neonatal complications. Angiotensin converting enzyme inhibitor or angiotensin II receptor blocker are rarely used during pregnancy, and there are few reports about the effect of them, because administration of these drugs during pregnancy may cause oligohydramnios, renal tubular dysplasia, hypocalvaria, pulmonary hypoplasia, intrauterine growth retardation, neonatal anuria and persistent ductus arteriosus. We report a case of neonatal acute renal failure by angiotensin II receptor blocker during pregnancy. In this case, the neonate with meconium aspiration was admitted to neonatal intensive care unit (NICU). During the NICU stay, neonatal anuria occurred, and there was a medical history that his mother took Candesartan Cilexeril (Atacand(R)), one of angiotensin II receptor blockers during pregnancy. The neonate showed intrinsic acute renal failure, so fluid was restricted and diuretics were administered to the neonate, and after 10 days, anuria improved.


Subject(s)
Female , Humans , Infant , Infant, Newborn , Pregnancy , Acute Kidney Injury , Angiotensin II , Angiotensin Receptor Antagonists , Angiotensins , Anuria , Benzimidazoles , Diuretics , Ductus Arteriosus , Fetal Growth Retardation , Hypertension , Intensive Care, Neonatal , Maternal Exposure , Meconium Aspiration Syndrome , Mothers , Oligohydramnios , Peptidyl-Dipeptidase A , Receptors, Angiotensin , Tetrazoles
SELECTION OF CITATIONS
SEARCH DETAIL